In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer’s disease
Authors:
Open Access
- 14 June 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-15
Abstract
Amyloid plaques are a hallmark of Alzheimer’s disease (AD) that develop in its earliest stages. Thus, non-invasive detection of these plaques would be invaluable for diagnosis and the development and monitoring of treatments, but this remains a challenge due to their small size. Here, we investigated the utility of manganese-enhanced MRI (MEMRI) for visualizing plaques in transgenic rodent models of AD across two species: 5xFAD mice and TgF344-AD rats. Animals were given subcutaneous injections of MnCl2 and imaged in vivo using a 9.4 T Bruker scanner. MnCl2 improved signal-to-noise ratio but was not necessary to detect plaques in high-resolution images. Plaques were visible in all transgenic animals and no wild-types, and quantitative susceptibility mapping showed that they were more paramagnetic than the surrounding tissue. This, combined with beta-amyloid and iron staining, indicate that plaque MR visibility in both animal models was driven by plaque size and iron load. Longitudinal relaxation rate mapping revealed increased manganese uptake in brain regions of high plaque burden in transgenic animals compared to their wild-type littermates. This was limited to the rhinencephalon in the TgF344-AD rats, while it was most significantly increased in the cortex of the 5xFAD mice. Alizarin Red staining suggests that manganese bound to plaques in 5xFAD mice but not in TgF344-AD rats. Multi-parametric MEMRI is a simple, viable method for detecting amyloid plaques in rodent models of AD. Manganese-induced signal enhancement can enable higher-resolution imaging, which is key to visualizing these small amyloid deposits. We also present the first in vivo evidence of manganese as a potential targeted contrast agent for imaging plaques in the 5xFAD model of AD.Keywords
All Related Versions
Funding Information
- Alzheimer's Society (AS-PhD-18B-015)
This publication has 46 references indexed in Scilit:
- Manganese in PET imaging: Opportunities and challengesJournal of Labelled Compounds and Radiopharmaceuticals, 2019
- MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery studyAlzheimer's Research & Therapy, 2018
- NIA‐AA Research Framework: Toward a biological definition of Alzheimer's diseaseAlzheimer's & Dementia, 2018
- Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approachNeurobiology of Aging, 2017
- Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementiaAlzheimer's & Dementia, 2016
- Fast in vivo imaging of amyloid plaques using μ-MRI Gd-staining combined with ultrasound-induced blood–brain barrier openingNeuroImage, 2013
- Development of Positron Emission Tomography β-Amyloid Plaque Imaging AgentsSeminars in Nuclear Medicine, 2012
- Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic miceNeurobiology of Aging, 2012
- Manganese-Enhanced Magnetic Resonance Imaging (MEMRI)2010
- In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agentMagnetic Resonance in Medicine, 2004